{"member_organisations": "", "identification_number": "678484329984-46", "fields_of_interest": "International co-operation and development, Research and innovation, Public Health", "head_office_address": "C/Mochol\u00ed, 2 Pol. Ind. Mochol\u00ed", "full_time_equivalent_fte": "0,25", "person_with_legal_responsibility": "DAMASO MOLERO SANCHEZ", "industry_forums": "", "grants": "", "inter_groups": "", "eu_initiatives": "-Bioeconomy  \n-H2020 \n-Pharmaceuticals in the environment \n-Eu trade policy  \n-Industrial policy \n-Acces to innovation", "level_of_interest": "European, global", "organisation_name": "3P BIOPHARMACEUTICALS, S.L. (3P)", "belgium_office_post_code": "", "number_of_persons_involved": "1", "person_in_charge_of_eu_relations": "DAMASO MOLERO SANCHEZ", "section": "II - In-house lobbyists and trade/business/professional associations", "source": "", "subsection": "Companies & groups", "belgium_office_phone": "", "overall_budget_turnover_as_a_range": "", "belgium_office_address": "", "no_geo_reference": true, "persons_accredited_for_access_to_european_parliament_premises": "", "registration_date": "05/02/2018", "estimate_of_costs_absolute_amount": "", "website_address": "http://www.3pbio.com", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "NOAIN", "membership": "ASEBIO: http://www.asebio.com/es/index.cfm", "head_office_post_code": "31110", "position": "DIRECTOR GENERAL", "financial_year_start_date": "01/01/2017", "head_office_country": "Spain", "number_of_ep_accredited_persons": "", "relevant_communication": "", "financial_year_end_date": "01/12/2017", "estimate_of_costs_as_a_range": "0-9999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "S.L.", "procurement": "", "customers": "", "belgium_office_post_box": "", "goals__remit": "3P Biopharmaceuticals is a European-based Contract Development and Manufacturing Organization (CDMO) specialized in the process development and GMP manufacture of biopharmaceutical and cell therapy products from early stages (POC,PC) up to clinical and commercial. \n \nThe Company offers an integral service for the process development and manufacture of biopharmaceutical products from: \n \nMicrobial fermentation \nMammalian cell culture", "belgium_office_city": "", "head_office_phone": "(+34)948346480"}